Financial Performance - Revenue for 2023 reached MYR 691,850,000, an increase of 15.2% from MYR 600,587,000 in 2022[130]. - Profit before taxation for 2023 was MYR 143,107,000, up 6.3% from MYR 134,758,000 in 2022[130]. - Profit after taxation for 2023 amounted to MYR 142,233,000, compared to MYR 133,301,000 in 2022, reflecting a growth of 6.9%[130]. - Total assets increased to MYR 1,159,041,000 in 2023, a rise of 15.7% from MYR 1,001,661,000 in 2022[130]. - Total liabilities rose to MYR 311,069,000, up from MYR 264,948,000 in 2022, indicating a growth of 17.4%[130]. - The Group achieved a remarkable compound annual growth rate (CAGR) exceeding 20.0% for both top-line and bottom-line performance over the past five years, driven by effective resource allocation and strategic planning[152]. - The Group's financial achievements in 2023 reflect a focus on business fundamentals and cost optimization, rather than merely a rebound from previous challenges[152]. Dividends and Reserves - The Board recommends a final dividend of HK$0.02 per share, subject to shareholder approval at the upcoming AGM[31]. - As of December 31, 2023, the Company's reserves available for distribution to shareholders amounted to approximately MYR30,963,000, an increase from MYR28,525,000 in 2022[37]. - The final dividend is payable on July 5, 2024, with a record date of June 17, 2024[33]. - As of December 31, 2023, the distributable reserves available to shareholders were approximately MYR30.96 million, compared to MYR28.53 million in 2022[47]. Business Operations and Strategy - There were no significant changes in the nature of the Group's principal activities during the year ended December 31, 2023[16]. - The Company has not carried out any business since its incorporation, focusing on investment holding[16]. - The Group is diversifying into the medical technology sector to meet growing market demands, leveraging automation solutions to enhance medical automation capabilities[78]. - The Group's vision is to be a leader in global automation solutions, committed to delivering high-quality, cost-effective solutions with the latest technology[77]. - The Group's strategic initiatives focused on diversification across products, segments, and geographical footprint, contributing to its business sustainability in a tumultuous year[152]. Charitable Contributions and Community Engagement - The Group made charitable donations amounting to approximately MYR115,000 in the year under review, an increase from MYR72,000 in 2022[44]. - The Group made a monetary contribution of MYR 50,000 to support the Penang state-led initiative for sustainable development and environmental protection[74]. - A total monetary contribution of MYR 66,000 was made by the Group for the Penang STEM 4.0 initiative, aimed at establishing learning centers in Science, Technology, Engineering, and Mathematics[88]. - The Group's initiatives include sponsoring charitable projects in Penang, contributing to community betterment and sustainable future generations[83]. - The Group made monetary contributions of MYR40,000 to support the establishment and management of a humane programme for stray dogs in Penang[92]. Health, Safety, and Environmental Compliance - The Group's internal health and safety policies ensure compliance with applicable laws and regulations, with quarterly inspections conducted[61]. - The Group did not record any material violations of health, work safety, and environmental laws during the year[63]. - The Group has not recorded any serious violations of health, safety, and environmental laws during the year, ensuring compliance with all major aspects of relevant regulations[66]. - The Group's commitment to environmental policies includes proper responses to chemical leaks and waste management through government-approved disposal companies[66]. - The Group has implemented the "Cost With No Waste" initiative since 2016 to minimize unnecessary waste and its impact on the ecosystem[70]. - The Group continues to promote recycling and waste management by providing recycling bins and educating employees on the "Reduce, Reuse and Recycle" concept[69]. Market and Segment Performance - The medical devices segment's contribution to overall revenue increased from 14.1% in 2022 to 21.4% in 2023, reflecting a year-on-year growth of 75.2%[142]. - The semiconductor segment experienced a year-on-year revenue increase of 23.6%, with its contribution rising from 14.0% to 15.0% of total revenue[147]. - The electro-optical segment's revenue contribution declined significantly from 19.5% to approximately 9.5% due to subdued demand for consumer electronics and smartphones[149]. - The automotive segment accounted for 71.7% of ATE revenue, showing a year-on-year growth of 31.9%[200]. - The Group's wafer level burn-in tester for SiC and back-end assembly solutions for hybrid pack power modules significantly drove growth in the automotive segment[199]. - The Group's revenue from external customers in the ATE segment was MYR 452.3 million, a 7.5% increase from MYR 420.7 million in 2022[195]. - The FAS segment's revenue from external customers increased by 33.2%, reaching MYR 239.6 million in 2023[195]. Governance and Compliance - The Company has maintained high transparency and effective communication with shareholders, receiving no complaints regarding shareholder communication in 2023[4]. - The Group is required to report on ESG information annually, publishing the ESG report on its website and the Stock Exchange[92]. - The Group has complied with relevant laws and regulations that significantly impact its business and operations during the year[104]. - The Board has adopted a board diversity policy to enhance decision-making capabilities and overall effectiveness, reviewing its implementation annually[138]. - No significant transactions or contracts involving directors were reported, except as disclosed in the financial statements[108]. - None of the Directors had interests in any competing business during the year[112].
槟杰科达(01665) - 2023 - 年度财报